Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Randomized Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I, Selected Stage IIa, or Isolated Lung Parenchymal Recurrent Non-Small Cell Lung Cancer: I-SABR

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03110978
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:09.460746+00:00
Published At
2026-04-16T00:00:00+00:00
Record Updated At
2026-04-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lung Atypical Carcinoid Tumor", "Lung Neuroendocrine Neoplasm", "Lung Non-Small Cell Squamous Carcinoma", "Minimally Invasive Lung Adenocarcinoma", "Neuroendocrine Carcinoma", "Recurrent Lung Adenocarcinoma", "Recurrent Lung Large Cell Carcinoma", "Recurrent Lung Non-Small Cell Carcinoma", "Stage I Lung Cancer AJCC v8", "Stage IA1 Lung Cancer AJCC v8", "Stage IA2 Lung Cancer AJCC v8", "Stage IA3 Lung Cancer AJCC v8", "Stage IB Lung Cancer AJCC v8", "Stage IIA Lung Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-16"
protocolSection.identificationModule.nctId
"NCT03110978"
protocolSection.identificationModule.officialTitle
"Phase II Randomized Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I, Selected Stage IIa, or Isolated Lung Parenchymal Recurrent Non-Small Cell Lung Cancer: I-SABR"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lung Atypical Carcinoid Tumor (protocolSection.conditionsModule.conditions)
  • Lung Neuroendocrine Neoplasm (protocolSection.conditionsModule.conditions)
  • Lung Non-Small Cell Squamous Carcinoma (protocolSection.conditionsModule.conditions)
  • Minimally Invasive Lung Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Neuroendocrine Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Lung Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Lung Large Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IA1 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IA2 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IA3 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.